Natalizumab is highly effective disease modifying agent for relapsing remitting multiple sclerosis. However, it’s associated with increased risk of progressive multifocal leukoencephalopathy (PML) caused by John Cunningham virus (JC virus)....

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call